Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

  title={Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.},
  author={Thomas F. Patterson and George R. Thompson and David W. Denning and Jay A. Fishman and Susan Hadley and Raoul Herbrecht and Dimitrios P. Kontoyiannis and Kieren A Marr and Vicki A. Morrison and M. Hong Nguyen and Brahm H. Segal and William J. Steinbach and David A. Stevens and Thomas J. Walsh and John R. Wingard and Jo-Anne H. Young and John E. Bennett},
  journal={Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
  volume={63 4},
  • T. Patterson, G. Thompson, J. Bennett
  • Published 15 August 2016
  • Medicine
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
It is important to realize that guidelines cannot always account for individual variation among patients. They are not intended to supplant physician judgment with respect to particular patients or special clinical situations. IDSA considers adherence to these guidelines to be voluntary, with the ultimate determination regarding their application to be made by the physician in the light of each patient's individual circumstances. 

Figures and Tables from this paper

Defining standards of CARE for invasive fungal diseases in the ICU

The aim of this article is to review the current recommendations for the diagnosis and treatment of invasive fungal infection in the ICU setting and to explore whether there are standards of care for

Challenges and Solution of Invasive Aspergillosis in Non-neutropenic Patients: A Review

The aim of this article is to present to clinicians a critical review on the management of IA in non-neutropenic patients.

Updated practice guidelines for the diagnosis and management of aspergillosis: challenges and opportunities.

The new IDSA guidelines provide a useful, up-to-date scaffold to assist in clinical decision-making about prevention, diagnosis and management of invasive aspergillosis and related diseases.

Challenges in the management of chronic pulmonary aspergillosis.

Three cases are presented that illustrate some of the most challenging aspects of caring for patients with CPA: specifically, antifungal drug resistance, drug interactions, coinfection with nontuberculous mycobacteria, and large-volume hemoptysis.

Diagnosis of invasive pulmonary aspergillosis in the intensive care unit: what we should concern and how to do better

In this review, the IPA diagnostic tests currently available and how they apply to ICU population are navigated and special attention is paid to the non-culture- based tests as well as what the future holds.

Antifungal Stewardship in Hematology: Reflection of a Multidisciplinary Group of Experts.

Treatment of invasive fungal diseases in cancer patients—Revised 2019 Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

Invasive fungal diseases remain a major cause of morbidity and mortality in cancer patients undergoing intensive cytotoxic therapy. The choice of the most appropriate antifungal treatment (AFT)

Special scenarios in the management of central nervous system aspergillosis: a case series and review of literature

A short review of four challenging cases touching on the varied aspects of management of CNS aspergillosis covering pathogenesis, diagnostic pitfalls, surgical and medical options and evidence-based guidelines for the management of the same are presented.

Characterization of patients with chronic pulmonary aspergillosis according to the new ESCMID/ERS/ECMM and IDSA guidelines

The comparison of both guidelines highlight that the combination of a chest CT scan with the performance of an Aspergillus‐specific IgG antibody assay are key diagnostic features to establish a guideline‐based diagnosis of CPA.



Salvage therapy for aspergillosis.

  • J. Bennett
  • Medicine
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2005
Suggestions for the regulatory approval of drugs solely on the basis of salvage therapy--that is, the use of an unlicensed drug to treat patients who have experienced failure with or who have been intolerant of an approved drug.

Outbreak of primary cutaneous aspergillosis related to intravenous arm boards.

Successful management of invasive aspergillosis presenting as pericarditis in an adult patient with chronic granulomatous disease

The first CGD patient with IA presenting as pericarditis where combined antifungal therapy resulted in a successful outcome is reported.

The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies.

The results suggest that different strategies for diagnosing IPA should be considered based on the underlying condition.

Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.

  • A. FreifeldE. Bow J. Wingard
  • Medicine, Biology
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2011
This document updates and expands the initial Infectious Diseases Society of America (IDSA) Fever and Neutropenia Guideline that was published in 1997 and first updated in 2002 and developed a clearer definition of which populations of patients with cancer may benefit most from antibiotic, antifungal, and antiviral prophylaxis.

Cyclical caspofungin for chronic pulmonary aspergillosis in sarcoidosis

A treatment regimen of cyclical caspofungin infusions in 10 patients with sarcoidosis and worsening CPA despite oral triazoles is reported.

Renal aspergilloma due to Aspergillus flavus.

A case of Aspergillus flavus colonization of the renal pelvis and upper ureter of a patient with concomitant urinary schistosomiasis is reported, emphasizing the importance of direct microscopic examination of urine specimens for prompt diagnosis of fungal infections of the urogenital system.

Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients

A noninvasive, objective, reproducible, and quantitative Aspergillus‐specific surrogate marker is needed for a more accurate assessment of the outcome of invasive aspergillosis (IA) in patients with

Caspofungin for treatment of invasive aspergillosis in Germany: results of a pre-planned subanalysis of an international registry

These real-life findings in Germany are consistent with the international findings from this registry and with findings from randomized studies.